Cargando…
Tocilizumab: Cytomegalovirus reactivation and acute hepatitis: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642224/ http://dx.doi.org/10.1007/s40278-021-06729-1 |
Ejemplares similares
-
Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021) -
Tocilizumab: Hepatitis-B viral reactivation with acute hepatitis following an off-label treatment: case report
Publicado: (2021) -
Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021) -
Hydrocortisone/tocilizumab: Cytomegalovirus haemorrhagic enterocolitis and off-label use: case report
Publicado: (2021) -
Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)